Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of lrsam1 as a molecular marker for hepatocellular carcinoma

A hepatocellular carcinoma and drug technology, applied in the field of biomedicine, can solve the problems of unclear expression and function of hepatocellular carcinoma

Active Publication Date: 2022-05-20
ACADEMY OF MILITARY MEDICAL SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Although it has been reported that the expression level of LRSAM1 is significantly upregulated in colorectal cancer patients, its expression and role in hepatocellular carcinoma are unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of lrsam1 as a molecular marker for hepatocellular carcinoma
  • Application of lrsam1 as a molecular marker for hepatocellular carcinoma
  • Application of lrsam1 as a molecular marker for hepatocellular carcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1: Under normal in vitro culture conditions, the effect of LRSAM1 on the growth of human hepatocellular carcinoma cells

[0042] 1. Using siRNA to down-regulate the expression level of LRSAM1 in hepatocellular carcinoma cells

[0043] 1) Cell seeding and transfection

[0044] The cells of the logarithmic growth phase hepatocellular carcinoma cell lines Huh7, HepG2, SK-Hep1, and BEL-7404 were respectively taken, digested with 0.25% trypsin, and after centrifugation, the cell mass at the bottom of the glass test tube was bounced by hand; Prepared DMEM medium containing 10% common fetal bovine serum, resuspended the cells, slowly and repeatedly pipetting the cells to make a single cell suspension, and then 2×10 per well 5 Cells were seeded into a six-well plate, so that the final volume of each well of the six-well plate was 1.5 mL; the six-well plate was then placed in an incubator for overnight culture; the cells were observed under an inverted microscope the ne...

Embodiment 2

[0080] Example 2: Effect of LRSAM1 on the growth of human hepatocellular carcinoma cells under soft agar colony formation experimental conditions

[0081] 1. Construction of HepG2 cell line with stable low expression of LRSAM1

[0082] Digest the HepG2 cells in the logarithmic growth phase with 0.25% trypsin, collect them in a glass centrifuge tube, cover with a sterile rubber stopper, centrifuge at 1200rpm for 4min, and resuspend with new DMEM medium supplemented with 10% FBS after centrifugation Cells (pay attention to gently pipetting the cell suspension, try to make a single cell suspension). Dilute the cells to an appropriate concentration according to the cell concentration, draw 10 μL of the diluted cell suspension, count the cells under a microscope, plant them into a six-well plate after calculation, and the number of cells per well is 5×10 4 After 24 hours, the state of the cells and the density of the cells were observed under a microscope.

[0083] When the cells...

Embodiment 3

[0115] Example 3: The effect of LRSAM1 on the growth of human hepatocellular carcinoma cells in vivo

[0116] Take cloned cells in logarithmic growth phase, such as stable cell lines of GFP-HepG2 and GFP-LRSAM1-HepG2; or HepG2 cell lines with stable expression of NC shRNA and stable low expression of LRSAM1 (LRSAM1 shRNA 549# or LRSAM1 shRNA 1636#) ;

[0117] First wash the cells with sterile normal saline, digest the cells with 0.25% trypsin, make a single cell suspension, put it into a glass test tube, centrifuge at 1200rpm / min for 4min, discard the old medium, and then use serum-free Resuspend the cells in DMEM medium and perform a cell count.

[0118] According to the number of nude mice used in the experiment and the number of cells per nude mouse, obtain the number of cells you need, centrifuge in a horizontal centrifuge, discard the old medium, and then use serum-free DMEM medium Resuspend the cells, then insert the Matrigel matrigel that was placed in a 4°C refrigera...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the application of LRSAM1 as a molecular marker of hepatocellular carcinoma in the preparation of hepatocellular carcinoma detection, prognosis or treatment products. The present inventors have found that, compared with normal healthy human liver tissues or cells or paracancerous tissues or cells of patients with hepatocellular carcinoma, the expression level of LRSAM1 in hepatocellular carcinoma tissues or cells of patients with hepatocellular carcinoma is significantly up-regulated, so LRSAM1 can be It is used as a molecular marker for auxiliary diagnosis and prognosis of hepatocellular carcinoma, and is used for preparing products for the detection and / or treatment of hepatocellular carcinoma. The kit for detecting hepatocellular carcinoma provided by the present invention can be used for auxiliary diagnosis and prognosis assessment of hepatocellular carcinoma; in addition, the LRSAM1 inhibitor can also be used to prepare a pharmaceutical composition for preventing or treating hepatocellular carcinoma for use in Clinical applications such as gene therapy and drug therapy for hepatocellular carcinoma.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to the application of LRSAM1 as a molecular marker of hepatocellular carcinoma. Background technique [0002] Liver cancer is a malignant tumor of the liver, which can be divided into two categories: primary and secondary. Hepatocellular carcinoma (HCC) is the most common primary liver cancer (accounting for about 70%-85% of all liver cancers), and its incidence rate ranks second among all tumors. It is the most common type of liver cancer in the world. It is one of the most common malignant tumors and the leading cause of cancer-related death. Although the prognosis of patients with HCC in the early stage is good, and its 5-year survival rate is higher than 70%, most patients have symptoms and have reached the advanced stage when they are diagnosed, which leads to the poor overall 5-year survival rate of HCC patients. More than 16%, HCC is highly malignant and fatal, and in m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6886A61K45/00A61P35/00
CPCC12Q1/6886A61K45/00A61P35/00C12Q2600/118C12Q2600/158
Inventor 王庆阳张纪岩偏丽丽黄晓峰赵敏张耀林秦诚
Owner ACADEMY OF MILITARY MEDICAL SCI